Dr. Daniel J. Powell: An Optimistic Doctor

Year Funded: 2017

Dr. Daniel J. Powell: An Optimistic Doctor

For women battling advanced ovarian cancer who have completed at least two rounds of chemotherapy without results, Daniel J. Powell, Jr., PhD, and colleagues at the University of Pennsylvania Perelman School of Medicine (Philadelphia, Pa.) are offering new hope.

Read More
Dr. Miguel Sena Esteves: Delivering Gene Therapy

Year Funded: 2005

Dr. Miguel Sena-Esteves: Taking an Engineering Approach to Biology

“I have no doubt that gene therapy is the path to a future of precision medicine,” says Miguel Sena-Esteves, PhD, of the University of Massachusetts Medical School (Worcester, Mass.). “Recent clinical trials show this unequivocally,

Read More
Dr. Kahlid Shah: Treating Brain Tumors – How can we approach this differently?

Year Funded: 2007

Dr. Khalid Shah: How can we approach this differently?

“Malignant glioblastomas have virtually defied all therapeutic modalities to date,” says Khalid Shah, MS, PhD, director of the Center for Stem Cell Therapeutics and Imaging and vice chair of the Department of Neurosurgery Research at Brigham and Women’s Hospital (Boston,

Read More
Dr. Alexander H. Stegh: Understanding the Genetics Behind Brain Tumors

Year Funded: 2012

Dr. Alexander H. Stegh: Understanding the Genetics Behind Brain Tumors

In his laboratory at the Northwestern University Robert H. Lurie Cancer Center (Chicago, Ill.), personal experience drives Alexander H. Stegh, PhD, to find new hope for people fighting Glioblastoma (GBM).

When Dr.

Read More
Dr. Matthis Stephan: Moving beyond Chemotherapy

Year Funded: 2018

Dr. Matthias Stephan: It’s Time to Outcompete Chemo as a Frontline Therapy

“Chemotherapy can be a relatively easy and inexpensive treatment protocol for physicians,” says Matthias Stephan, MD, PhD, of the Fred Hutchinson Cancer Research Center (Seattle, Wash.), “but it’s not very efficient or targeted.

Read More

Join the Alliance

  • This field is for validation purposes and should be left unchanged.